Lactoperoxidase and human airway host defense

Corinne Wijkstrom-Frei, Souheil El-Chemaly, Radia Ali-Rachedi, Cynthia Gerson, Miguel Cobas, Rosanna Forteza, Matthias A Salathe, Gregory E Conner

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

The lactoperoxidase (LPO) antibiotic system is a well-characterized component of mammary and salivary gland secretions. Because LPO has been shown to function in ovine airways, human airway tissue and secretions were examined for the presence of LPO and its substrate, the anion thiocyanate (SCN-). In addition, human airway secretions were tested for LPO-mediated antibacterial activity, and LPO's activity was assessed against some human airway pathogens. The data showed that normal human airway secretions contained LPO enzyme activity (0.65 ± 0.09 μg/mg secreted protein; n = 17), and Western blots of secretions demonstrated bands of the expected sizes for LPO. LPO mRNA was detected in trachea by sequencing PCR-amplified cDNA. SCN-, LPO's substrate, was present in undiluted airway secretions at concentrations sufficient for LPO catalysis (0.46 ± 0.19 mM; n = 8), and diluted secretions contained antibacterial activity with LPO-like properties. Immunocytochemistry localized LPO to submucosal glands in human bronchi. Finally, as expected based on the known antibacterial spectrum of the LPO system, airway secretions showed LPO-dependent activity against Pseudomonas aeruginosa. In addition, the airway LPO system was shown to be effective against Burkholderia cepacia and Haemophilus influenzae. Thus, a functional LPO system exists in human airways and may contribute to airway host defense against infection.

Original languageEnglish
Pages (from-to)206-212
Number of pages7
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume29
Issue number2
DOIs
StatePublished - Aug 1 2003

Fingerprint

Lactoperoxidase
Burkholderia cepacia
Haemophilus influenzae
Enzyme activity
Pathogens
Substrates
Bronchi
Human Mammary Glands
Trachea
Salivary Glands
Catalysis

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

Cite this

Lactoperoxidase and human airway host defense. / Wijkstrom-Frei, Corinne; El-Chemaly, Souheil; Ali-Rachedi, Radia; Gerson, Cynthia; Cobas, Miguel; Forteza, Rosanna; Salathe, Matthias A; Conner, Gregory E.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 29, No. 2, 01.08.2003, p. 206-212.

Research output: Contribution to journalArticle

Wijkstrom-Frei, C, El-Chemaly, S, Ali-Rachedi, R, Gerson, C, Cobas, M, Forteza, R, Salathe, MA & Conner, GE 2003, 'Lactoperoxidase and human airway host defense', American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 2, pp. 206-212. https://doi.org/10.1165/rcmb.2002-0152OC
Wijkstrom-Frei C, El-Chemaly S, Ali-Rachedi R, Gerson C, Cobas M, Forteza R et al. Lactoperoxidase and human airway host defense. American Journal of Respiratory Cell and Molecular Biology. 2003 Aug 1;29(2):206-212. https://doi.org/10.1165/rcmb.2002-0152OC
Wijkstrom-Frei, Corinne ; El-Chemaly, Souheil ; Ali-Rachedi, Radia ; Gerson, Cynthia ; Cobas, Miguel ; Forteza, Rosanna ; Salathe, Matthias A ; Conner, Gregory E. / Lactoperoxidase and human airway host defense. In: American Journal of Respiratory Cell and Molecular Biology. 2003 ; Vol. 29, No. 2. pp. 206-212.
@article{a4df48979ba24f93af515ec19335f6be,
title = "Lactoperoxidase and human airway host defense",
abstract = "The lactoperoxidase (LPO) antibiotic system is a well-characterized component of mammary and salivary gland secretions. Because LPO has been shown to function in ovine airways, human airway tissue and secretions were examined for the presence of LPO and its substrate, the anion thiocyanate (SCN-). In addition, human airway secretions were tested for LPO-mediated antibacterial activity, and LPO's activity was assessed against some human airway pathogens. The data showed that normal human airway secretions contained LPO enzyme activity (0.65 ± 0.09 μg/mg secreted protein; n = 17), and Western blots of secretions demonstrated bands of the expected sizes for LPO. LPO mRNA was detected in trachea by sequencing PCR-amplified cDNA. SCN-, LPO's substrate, was present in undiluted airway secretions at concentrations sufficient for LPO catalysis (0.46 ± 0.19 mM; n = 8), and diluted secretions contained antibacterial activity with LPO-like properties. Immunocytochemistry localized LPO to submucosal glands in human bronchi. Finally, as expected based on the known antibacterial spectrum of the LPO system, airway secretions showed LPO-dependent activity against Pseudomonas aeruginosa. In addition, the airway LPO system was shown to be effective against Burkholderia cepacia and Haemophilus influenzae. Thus, a functional LPO system exists in human airways and may contribute to airway host defense against infection.",
author = "Corinne Wijkstrom-Frei and Souheil El-Chemaly and Radia Ali-Rachedi and Cynthia Gerson and Miguel Cobas and Rosanna Forteza and Salathe, {Matthias A} and Conner, {Gregory E}",
year = "2003",
month = "8",
day = "1",
doi = "10.1165/rcmb.2002-0152OC",
language = "English",
volume = "29",
pages = "206--212",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Lactoperoxidase and human airway host defense

AU - Wijkstrom-Frei, Corinne

AU - El-Chemaly, Souheil

AU - Ali-Rachedi, Radia

AU - Gerson, Cynthia

AU - Cobas, Miguel

AU - Forteza, Rosanna

AU - Salathe, Matthias A

AU - Conner, Gregory E

PY - 2003/8/1

Y1 - 2003/8/1

N2 - The lactoperoxidase (LPO) antibiotic system is a well-characterized component of mammary and salivary gland secretions. Because LPO has been shown to function in ovine airways, human airway tissue and secretions were examined for the presence of LPO and its substrate, the anion thiocyanate (SCN-). In addition, human airway secretions were tested for LPO-mediated antibacterial activity, and LPO's activity was assessed against some human airway pathogens. The data showed that normal human airway secretions contained LPO enzyme activity (0.65 ± 0.09 μg/mg secreted protein; n = 17), and Western blots of secretions demonstrated bands of the expected sizes for LPO. LPO mRNA was detected in trachea by sequencing PCR-amplified cDNA. SCN-, LPO's substrate, was present in undiluted airway secretions at concentrations sufficient for LPO catalysis (0.46 ± 0.19 mM; n = 8), and diluted secretions contained antibacterial activity with LPO-like properties. Immunocytochemistry localized LPO to submucosal glands in human bronchi. Finally, as expected based on the known antibacterial spectrum of the LPO system, airway secretions showed LPO-dependent activity against Pseudomonas aeruginosa. In addition, the airway LPO system was shown to be effective against Burkholderia cepacia and Haemophilus influenzae. Thus, a functional LPO system exists in human airways and may contribute to airway host defense against infection.

AB - The lactoperoxidase (LPO) antibiotic system is a well-characterized component of mammary and salivary gland secretions. Because LPO has been shown to function in ovine airways, human airway tissue and secretions were examined for the presence of LPO and its substrate, the anion thiocyanate (SCN-). In addition, human airway secretions were tested for LPO-mediated antibacterial activity, and LPO's activity was assessed against some human airway pathogens. The data showed that normal human airway secretions contained LPO enzyme activity (0.65 ± 0.09 μg/mg secreted protein; n = 17), and Western blots of secretions demonstrated bands of the expected sizes for LPO. LPO mRNA was detected in trachea by sequencing PCR-amplified cDNA. SCN-, LPO's substrate, was present in undiluted airway secretions at concentrations sufficient for LPO catalysis (0.46 ± 0.19 mM; n = 8), and diluted secretions contained antibacterial activity with LPO-like properties. Immunocytochemistry localized LPO to submucosal glands in human bronchi. Finally, as expected based on the known antibacterial spectrum of the LPO system, airway secretions showed LPO-dependent activity against Pseudomonas aeruginosa. In addition, the airway LPO system was shown to be effective against Burkholderia cepacia and Haemophilus influenzae. Thus, a functional LPO system exists in human airways and may contribute to airway host defense against infection.

UR - http://www.scopus.com/inward/record.url?scp=0042703130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042703130&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2002-0152OC

DO - 10.1165/rcmb.2002-0152OC

M3 - Article

C2 - 12626341

AN - SCOPUS:0042703130

VL - 29

SP - 206

EP - 212

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 2

ER -